Analysis of the protein profile of the venoms of snakes Bothrops asper, Bothrocophias myersi and Crotalus durissus from the Colombian Andean Region obtained by RP-HPLC / Análisis del perfil proteico de los venenos de Bothrops asper, Bothrocophias myersi y Crotalus durissus serpientes de la Región Andina en Colombia obtenidos por RP-HPLC

ABSTRACT Snake venoms comprise a highly complex mixture of proteins, and there is also a high interspecific and intraspecific variability in their composition, even in the same region. Our aim was to compare the composition of the venoms of Bothrocophias myersi, Crotalus durissus, and Bothrops asper, snakes from the Colombian Andean region by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The venoms were given to the research group under an agreement with Fundación Zoológica de Cali. The venoms pool was obtained by manual extraction, lyophilized and frozen. The venom protein was quantified by direct measurement with Nanodrop® 280 nm. The protein composition was established by RP-HPLC, using a Lichosper 100 RP, C18 column (250X4 mm) with a pore size of 5-m, as well as by Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE). The highest quantity of protein was found in the venom of B. myersi (108.6 mg/ mL) followed by C. durissus (78.1 mg/mL) and B. asper (74.1 mg/mL). All venoms showed bands of 15 and 50 KDa by using SDS-PAGE. B. myersi venom chromatogram exhibited 16 peaks by RP-HPLC. We conclude that the composition of the three venoms is quite similar, being phospholipase A2 the common protein therein, and together with metalloproteinases they were the most abundant protein families in the venom of B. myersi. SDS-PAGE and RP-HPLC techniques allow a first approach to the profile of the venoms, which in turn could clarify the clinical syndrome produced.

RESUMEN Los venenos de las serpientes comprenden una mezcla compleja de proteínas, y existe una alta variabilidad interespecífica e intra-específica en su composición, incluso en la misma región. Nuestro objetivo fue comparar la composición de los venenos de Bothrocophias myersi, Crotalus durissus y Bothrops asper de la región andina de Colombia, mediante cromatografía líquida de alta eficiencia en fase reversa (RP-HPLC). Los venenos fueron entregados al grupo de investigación mediante un convenio con la Fundación Zoológica de Cali. El pool de venenos fue obtenido por extracción manual, liofilizado y congelado. La proteína de los venenos fue cuantificada por Absorbancia 280nm por medición directa con Nanodrop®. La composición proteica se estableció por RP-HPLC, utilizando una columna Lichosper 100 RP, C18 (250X4 mm) con un tamaño de poro de 5-jm, así como por electroforesis en gel dodecil sulfato de sodio-poliacrilamida (SDS-PAGE). La mayor cantidad de proteínas se encontró en el veneno de B. myersi (108.6 mg/mL), seguido de C. durissus (78.1 mg/mL) y B. asper (74.1 mg/mL). Todos los venenos mostraron bandas de 15 y 50 KDa por SDS-PAGE. El cromatograma de B. myersi exhibió 16 picos por RP-HPLC. Concluimos que la composición de los tres venenos es bastante similar, siendo la fosfolipasa A2 la proteína común en estos y junto con las metaloproteinasas fueron las familias de proteínas más abundantes en el veneno de B. myersi. Las técnicas de SDS-PAGE y el RP-HPLC permiten un primer acercamiento al perfil de los venenos, lo que a su vez podría contribuir a esclarecer el síndrome clínico producido.

Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect

Background Arthritis is a set of inflammatory conditions that induce aching, stiffness, swelling, pain and may cause functional disability with severe consequences to the patient's lives. These are multi-mediated pathologies that cannot be effectively protected and/or treated. Therefore, the aim of this study was to establish a new model of acute arthritis, using a Lys49-PLA2 (Bothrops asper myotoxin II; MT-II) to induce articular inflammation. Methods The articular inflammation was induced by MT-II (10 μg/joint) injection into the left tibio-tarsal or femoral-tibial-patellar joints. Cellular influx was evaluated counting total and differential cells that migrated to the joint. The plasma extravasation was determined using Evans blue dye. The edematogenic response was evaluated measuring the joint thickness using a caliper. The articular hypernociception was determined by a dorsal flexion of the tibio-tarsal joint using an electronic pressure-meter test. The mediators involved in the articular hypernociception were evaluated using receptor antagonists and enzymatic inhibitors. Results Plasma extravasation in the knee joints was observed 5 and 15 min after MT-II (10 μg/joint) injection. MT-II also induced a polymorphonuclear cell influx into the femoral-tibial-patellar joints observed 8 h after its injection, a period that coincided with the peak of the hyperalgesic effect. Hyperalgesia was inhibited by the pretreatment of the animals with cyclooxygenase inhibitor indomethacin, with type-2 cyclooxygenase inhibitor celecoxib, with AACOCF3 and PACOCF3, inhibitors of cytosolic and Ca2+-independent PLA2s, respectively, with bradykinin B2 receptor antagonist HOE 140, with antibodies against TNFα, IL-1β, IL-6 and CINC-1 and with selective ET-A (BQ-123) and ET-B (BQ-788) endothelin receptors antagonists. The MT-II-induced hyperalgesia was not altered by the lipoxygenase inhibitor zileuton, by the bradykinin B1 receptor antagonist Lys-(Des-Arg9,Leu8)-bradykinin, by the histamine and serotonin antagonists promethazine and methysergide, respectively, by the nitric oxide inhibitor LNMMA and by the inhibitor of matrix 1-, 2-, 3-, 8- and 9- metalloproteinases GM6001 (Ilomastat). Conclusion These results demonstrated the multi-mediated characteristic of the articular inflammation induced by MT-II, which demonstrates its relevance as a model for arthritis mechanisms and treatment evaluation.(AU)

Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect

Abstract Background Arthritis is a set of inflammatory conditions that induce aching, stiffness, swelling, pain and may cause functional disability with severe consequences to the patients lives. These are multi-mediated pathologies that cannot be effectively protected and/or treated. Therefore, the aim of this study was to establish a new model of acute arthritis, using a Lys49-PLA2 (Bothrops asper myotoxin II; MT-II) to induce articular inflammation. Methods The articular inflammation was induced by MT-II (10 g/joint) injection into the left tibio-tarsal or femoral-tibial-patellar joints. Cellular influx was evaluated counting total and differential cells that migrated to the joint. The plasma extravasation was determined using Evans blue dye. The edematogenic response was evaluated measuring the joint thickness using a caliper. The articular hypernociception was determined by a dorsal flexion of the tibio-tarsal joint using an electronic pressure-meter test. The mediators involved in the articular hypernociception were evaluated using receptor antagonists and enzymatic inhibitors. Results Plasma extravasation in the knee joints was observed 5 and 15 min after MT-II (10 g/joint) injection. MT-II also induced a polymorphonuclear cell influx into the femoral-tibial-patellar joints observed 8 h after its injection, a period that coincided with the peak of the hyperalgesic effect. Hyperalgesia was inhibited by the pretreatment of the animals with cyclooxygenase inhibitor indomethacin, with type-2 cyclooxygenase inhibitor celecoxib, with AACOCF3 and PACOCF3, inhibitors of cytosolic and Ca2+-independent PLA2s, respectively, with bradykinin B2 receptor antagonist HOE 140, with antibodies against TNF, IL-1, IL-6 and CINC-1 and with selective ET-A (BQ-123) and ET-B (BQ-788) endothelin receptors antagonists. The MT-II-induced hyperalgesia was not altered by the lipoxygenase inhibitor zileuton, by the bradykinin B1 receptor antagonist Lys-(Des-Arg9,Leu8)-bradykinin, by the histamine and serotonin antagonists promethazine and methysergide, respectively, by the nitric oxide inhibitor LNMMA and by the inhibitor of matrix 1-, 2-, 3-, 8- and 9- metalloproteinases GM6001 (Ilomastat). Conclusion These results demonstrated the multi-mediated characteristic of the articular inflammation induced by MT-II, which demonstrates its relevance as a model for arthritis mechanisms and treatment evaluation.

First record of Porocephalus cf. clavatus (Pentastomida: Porocephalida) as a parasite on Bothrops asper (Squamata: Viperidae) in Costa Rica / Primeiro registro de Porocephalus cf. clavatus (Pentastomida: Porocephalida) como um parasita em Bothrops asper (Squamata: Viperidae) na Costa Rica

Abstract Pentastomids are parasites that infect respiratory cavities of vertebrates, they are pretty common but poorly known in wildlife veterinary. A Bothrops asper snake (Garman, 1884) was captured in the Caribbean region of Costa Rica and had its lung infested with pentastomids, identified as ca Porocephalus clavatus (Wyman, 1845). This represents the first record of Porocephalus (Humboldt, 1812) on B. asper as well as P. cf. clavatus in Costa Rica. Further studies are needed to clarify their taxonomic position, images and scanning electron microscopy photographs (SEM) of the specimens are given.

Resumo Pentastomídeos sâo parasitas que infectam as cavidades respiratórias dos vertebrados, eles são bastante comuns, mas pouco conhecido nos animais silvestres. Uma Bothrops asper (Garman, 1884) foi capturada na região do Caribe da Costa Rica e teve seu pulmão infestado de pentastomídeos, identificados como ca Porocephalus clavatus (Wyman, 1845). Isto representa o primeiro registro de Porocephalus (Humboldt, 1812) em B. asper, assim como P. cf. clavatus na Costa Rica. Mais estudos detalhados são necessários para esclarecer sua posição taxonómica. Imagens e fotografias de microscopia electrónica de varredura (MEV) dos espécimes são dadas.

Isolation and functional characterization of a basic phospholipase A2 from Colombian Bothrops asper venom / Aislamiento y caracterización funcional de una fosfolipasa A2 básica del veneno de Bothrops asper de Colombia

Antecedentes: las mordeduras de serpientes representan un problema de salud pública relevante en muchas regiones del mundo, particularmente en los países tropicales y subtropicales de África, Asia, América Latina y Oceanía. Los venenos de serpientes son mezclas complejas de enzimas y proteínas tóxicas, donde los componentes más importantes y abundantes que dañan los músculos en los venenos de serpientes son las fosfolipasas A2 (PLA2). Objetivo: Aislar y caracterizar una fosfolipasa A2 del veneno de Venezuela Bothrops para obtener información sobre la composición del veneno de esta especie. Materiales y métodos: La cromatografía de intercambio catiónico seguida de HPLC de fase inversa se usó para purificar la proteína. La espectrometría de masas se utilizó para determinar su masa molecular. La caracterización bioquímica se realizó utilizando un sustrato sintético (ácido 4-nitro-3-octanoiloxi-benzoico). La actividad miotóxica y de inducción de edema de la toxina se probó en ratones, midiendo la actividad de la creatina quinasa plasmática y el diámetro de la almohadilla de la pata, respectivamente. Además, se examinó la actividad citotóxica de mioblastos y miotubos C2C12 del músculo esquelético murino. Resultados: se purificó una PLA2 de Bothrops asper veneno de Colombia (BaspCol-PLA2). Su masa molecular fue de 13974.6 Da. La enzima hidrolizó un sustrato sintético con un KM de 3.11 mM y un VMax de 4.47 nmol / min, mostrando una actividad máxima a 40 ° C y a pH 8.0. La PLA2 requería Ca2 + para la actividad. La adición de Mg2 +, Cd2 +, Mn2 + y Zn2 + (10 mM) en presencia de baja concentración de Ca2 + (1 mM) disminuyó la actividad de la enzima. La sustitución de Ca2 + por los cationes divalentes mencionados también redujo la actividad a niveles similares a los de la ausencia de Ca2 +. Tres fragmentos internos (CCFVHDCCYGK, AAAI / LCFRDNI / LNTYNDKK, DAAI / LCFR) identificada mediante un análisis de espectrometría de masas mostró similitud con las PLA2 de B. asper informadas previamente. En ratones, BaspCol-PLA2 indujo un notable efecto miotóxico local y un edema moderado en la almohadilla del pie. In vitro, esta enzima indujo un efecto citotóxico tanto en los mioblastos como en los miotubos. Además, se clasificó como PLA2 débilmente anticoagulante, mostrando este efecto en concentraciones entre 3 y 10 µg / mL cuando se usa plasma humano. Conclusiones: Una PLA2 se purificó y se llamó BaspCol-PLA2, esta enzima mostró actividad catalítica y una masa molecular de 13974.6 Da. La toxina mostró actividades miotóxicas, formadoras de edema, anticoagulantes y citotóxicas. BaspCol-PLA2 indujo un notable efecto miotóxico local y un edema moderado en la almohadilla del pie. In vitro, esta enzima indujo un efecto citotóxico tanto en los mioblastos como en los miotubos. Además, se clasificó como PLA2 débilmente anticoagulante, mostrando este efecto en concentraciones entre 3 y 10 µg / mL cuando se usa plasma humano. Conclusiones: Una PLA2 se purificó y se llamó BaspCol-PLA2, esta enzima mostró actividad catalítica y una masa molecular de 13974.6 Da. La toxina mostró actividades miotóxicas, formadoras de edema, anticoagulantes y citotóxicas. BaspCol-PLA2 indujo un notable efecto miotóxico local y un edema moderado en la almohadilla del pie. In vitro, esta enzima indujo un efecto citotóxico tanto en los mioblastos como en los miotubos. Además, se clasificó como PLA2 débilmente anticoagulante, mostrando este efecto en concentraciones entre 3 y 10 µg / mL cuando se usa plasma humano. Conclusiones: Una PLA2 se purificó y se llamó BaspCol-PLA2, esta enzima mostró actividad catalítica y una masa molecular de 13974.6 Da. La toxina mostró actividades miotóxicas, formadoras de edema, anticoagulantes y citotóxicas. esta enzima mostró actividad catalítica y masa molecular de 13974.6 Da. La toxina mostró actividades miotóxicas, formadoras de edema, anticoagulantes y citotóxicas. esta enzima mostró actividad catalítica y masa molecular de 13974.6 Da. La toxina mostró actividades miotóxicas, formadoras de edema, anticoagulantes y citotóxicas.

Evaluación biológica preliminar de extractos vegetales utilizados en la medicina tradicional de la Sierra Nevada de Santa Marta contra el veneno de la Bothrops asper / Preliminary biological evaluation of plants extracts used in the Sierra Nevada de Santa Marta against the snake Bothrops asper venom

La mordedura de serpientes constituye un problema de salubridad importante en muchos países tropicales y subtropicales, con un estimado de 2,5 millones de personas envenenadas cada año. En Colombia las especies Bothropsasper y Bothropsatrox son las causantes del 70 al 90 % de los accidentes registrados. Se estima que el 60 % de estos accidentes son inicialmente tratados por curanderos tradicionales utilizando plantas medicinales en diferentes preparaciones. Este estudio evaluó la capacidad inhibitoria de cinco especies contra el efecto proteolítico y hemolítico indirecto inducido por el veneno de B. asper en ensayos in vitro. Las especies, que fueron seleccionadas de acuerdo a su uso en la medicina tradicional por parte de las comunidades campesinas de la Sierra Nevada de Santa Marta, fueron, Aristolochia máxima, Cissampelospareira, Equisetumbogotense, Mucunacfpruriens y una especie de la familia Asteraceae. La planta E. bogotense mostró los mayores porcentaje de inhibición contra la actividad de las fosfolipasas A2 (42,29 %), así como la mayor precipitación de las proteínas en un rango de masas moleculares de 28,2 y 94,43 KDa. Al fraccionar el extracto de E. bogotense se obtuvieron cinco fracciones, las cuales presentaron un porcentaje de inhibición de 36,6 ± 1,07 a 46,1 ± 13,6. Adicionalmente se detectaron por métodos cualitativos núcleos como, alcaloides, esteroides y/o triterpenos, taninos, cumarinas y leucoantocianidinas. En estudio se reporta la actividad antiofídica en ensayos in vitro de la especie E. bogotense contra el veneno de la especie B.asper. (DUAZARY 2012 No. 2, 140 - 150).

Correlation of the inhibitory activity of phospholipase A2 snake venom and the antioxidant activity of Colombian plant extracts

Snakebite continues to be a significant health problem in many countries of Latin America. Even though, there has been an improvement in the antivenom therapy, the local effects caused by myotoxic phospholipases A2 (PLA2) present in the venoms, still persist. In search for alternatives to antagonize the PLA2 activity of Bothrops asper's venom, 36 extracts belonging to seventeen families of vascular plants and bryophytes were screened. A significant inhibition of the enzymatic activity of PLA2 present in B. asper's whole venom was seen in eleven of these extracts. In addition, the antioxidant activity of all the extracts was evaluated. The results evidenced a significant statistical correlation between extracts with an inhibitory effect against PLA2 and those with an antioxidant activity. Moreover, the amount of phenols was quantified finding a relationship between the bioactivity and the presence of these compounds. Nine extracts were screened against a fraction of the venom rich in basic PLA2 (Fx-V B. asper), exhibiting an inhibitory effect on PLA2 activity of this fraction in a range from 30-80 percent. This activity was supported by the inhibition that these extracts presented on the cytotoxicity caused by Fx-V B. asper on murine skeletal muscle C2C12 myoblasts. The results obtained, could point to minimize efforts in the search of PLA2 inhibitors by focusing in samples with known antioxidant properties.

Veneno de cobra continua a ser um problema importante de saúde em muitos países da América Latina. Apesar dos avanços na terapia antiveneno, os efeitos locais causados por fosfolipases A2 miotóxica (PLA2) presentes no veneno, ainda persistem. Em busca de alternativas para antagonizar a atividade da PLA2 do veneno de Bothrops asper, foram selecionados 36 extratos pertencentes a dezessete famílias de plantas vasculares e briófitas. Uma inibição significativa da atividade enzimática de PLA2 presente no veneno de B. asper foi observada em onze extratos. Além disso, a atividade antioxidante dos extratos foi avaliada. Os resultados evidenciaram uma correlação estatisticamente significativa entre os extratos com ação inibitória contra a PLA2 e aqueles com atividade antioxidante. Também, a quantidade de fenóis foi avaliada e foi encontrada uma relação entre a atividade biológica e a presença dessas substâncias. Nove extratos foram testados contra uma fração do veneno rico em PLA2 básica (Fx-V B. asper), resultando em um efeito inibitório na atividade desta fração da PLA2 na faixa de 30-80 por cento. Esta atividade foi apoiada pela inibição que esses extratos apresentaram na citotoxicidade causada pelo Fx-V B. asper sobre mioblastos C2C12 de músculo esquelético de murino. Os resultados podem indicar a minimização dos esforços na busca de inibidores da PLA2, com foco nas amostras com propriedades antioxidantes conhecidas.

EVALUACIÓN DE LAS PROPIEDADES ANTIOFÍDICAS DEL EXTRACTO ETANÓLICO Y FRACCIONES OBTENIDAS DE Renealmia alpinia (Rottb) Mass (Zingiberaceae) CULTIVADA IN VITRO / ANTIOPHIDIAN PROPERTIES EVALUATION OF ETHANOL EXTRACT AND FRACTIONS OBTAINED FROM Renealmia alpinia (Rottb) Mass (Zingiberaceae)CULTIVATED IN VITRO

Los extractos vegetales constituyen una fuente rica de moléculas farmacológicamente activas, cuya aplicación en medicina tradicional permite un acercamiento a potenciales actividades biológicas. En este trabajo se evalúa la capacidad inhibitoria de extractos etanólicos de hojas, raicillas y fracciones obtenidas por cromatografía en columna de Renealmia alpinia (Rottb) Mass, cultivada in vitro, sobre los efectos hemolítico indirecto, proteolítico y coagulante inducidos por el veneno de Bothrops asper. La actividad hemolítica indirecta es inhibida en mayor medida por la fracción 7-8 (47,3 ± 2,20%), seguida en su orden por los extractos de raicillas (32,6 #177; 6,90%) y hojas (24,2 ± 4,43%) de origen in vitro y hojas ex vitro (16,2 ± 3,88%). La actividad proteolítica se inhibe ampliamente por los extractos de hojas tanto in vitro como ex vitro sin diferencias significativas. Contra la actividad coagulante se registra una mayor neutralización por parte de las raicillas in vitro (81,73 ± 9,94s). Se descarta un potencial mecanismo de acción proteolítico de Renealmia alpinia sobre el veneno de Bothrops asper dado que no se producen cambios en los patrones electroforéticos del veneno. Los resultados viabilizan la aplicación de Renealmia alpinia como coadyuvante en el tratamiento del accidente ofídico y sustentan la utilidad de la micropropagación para la producción masiva de componentes activos.

Plant extracts are a rich source of pharmacologically active molecules. Their application allows a tradicional medicine approach to potential biological acitivities. This paper evaluates the inhibitory capacity of ethanolic extracts of leaves and little roots and also fractions chromatographically fractions obtained from Renealmia alpinia (Rottb) Mass, cultured in vitro, on the indirect hemolytic activity, proteolytic activity and coagulant activity induced by the Bothrops asper venom. Indirect hemolytic activity is inhibited to a greater extent by the fraction 7-8 (47.3 ± 2.20%) followed in order by the extracts from little roots (32.6 ± 6.90%) and leaves (24.2 ± 4.43%). They came from in vitro and ex vitro leaves (16.2 ± 3.88%). The proteolytic activity is largely inhibited by the leaves extracts in vitro and ex vitro without significant differences between them. Little roots in vitro showed the highest neutralization effect on coagulant activity (81.73 ± 9.949s). Proteolytic activity from Renealmia alpinia extracts on Bothrops asper venom is ruled out since there are not changes in the electrophoretic pattern of the venom. The results make possible the implementation of Renealmia alpinia as adjuvant for the treatment of ophidic accidents and sustain the value of micropropagation for mass production of active components.

Functional and structural characterization of phospholipases A² isolated from Bothrops asper snake venom in Panamá

Envenoming by Bothrops snakes is the most serious type of envenoming from the medical and economic point of view in Central America. Bothrops asper is responsible for 90% of the snakebites registered in Panamá every year. Despite its medical and economic relevance, only the venom of Costa Rican and Guatemalan populations of this species has been studied to some detail, and there is very little information on intraspecies variability in venom composition and toxicity. In this study the crude venom of B. asper from Panamá was characterized and its pharmacological and biochemistry activities were investigated with standard laboratory assays. Furthermore, we described the isolation, functional and structural characterization of four basic phospholipases A2, namely MTX-I, MTX-II, MTX-III, MTX-IV, and a new acid phospholipase A2 called Basp-I-PLA2. The proteins were isolated from the crude venom by a combination of two chromatographic steps, using ion-exchange chromatography on CM-Sepharose (0.05 M NH4HCO3 pH 8.1 buffer), and hydrophobic chromatography on Phenyl-Sepharose (0.05 M Tris-HCl pH 7.4), followed by concentration gradient from 4 to 0 M NaCl at 25°C in the same buffer. Analyses of phospholipids hydrolyzed by these enzymes have shown that all phospholipases belong to type A2. The acidic isoform demonstrated more catalytic activity than basic PLA2s. This enzyme was more active on substrates such as phosphotidylcholine and phosphatidylglycerol.(AU)

Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper

A serine proteinase with thrombin-like activity was isolated from the venom of the Central American pit viper Bothrops asper. Isolation was performed by a combination of affinity chromatography on aminobenzamidine-Sepharose and ion-exchange chromatography on DEAE-Sepharose. The enzyme accounts for approximately 0.13 percent of the venom dry weight and has a molecular mass of 32 kDa as determined by SDS-PAGE, and of 27 kDa as determined by MALDI-TOF mass spectrometry. Its partial amino acid sequence shows high identity with snake venom serine proteinases and a complete identity with a cDNA clone previously sequenced from this species. The N-terminal sequence of the enzyme is VIGGDECNINEHRSLVVLFXSSGFL CAGTLVQDEWVLTAANCDSKNFQ. The enzyme induces clotting of plasma (minimum coagulant dose = 4.1 µg) and fibrinogen (minimum coagulant dose = 4.2 µg) in vitro, and promotes defibrin(ogen)ation in vivo (minimum defibrin(ogen)ating dose = 1.0 µg). In addition, when injected intravenously in mice at doses of 5 and 10 µg, it induces a series of behavioral changes, i.e., loss of the righting reflex, opisthotonus, and intermittent rotations over the long axis of the body, which closely resemble the `gyroxin-like' effect induced by other thrombin-like enzymes from snake venoms.

Hiperinmunización de ovinos contra veneno de Bothrops asper del estado Zulia Venezuela: estudio preliminar / Hyperimmunization of ovines against Bothrops asper venom from the Zulia state Venezuela: preliminary study

Un grupo de cuatro ovinos sanos se inmunizó con veneno de Bothrops asper, para estudiar el desarrollo de la respuesta inmune, inducida por la aplicación de un esquema de hiperinmunización. Se tomaron muestras de sangre cada siete días en nueve oportunidades, con el suero obtenido se realizaron pruebas de neutralización en ratones. Se determinó la DE 50, la cual se expresó en µg de veneno neutralizado por ml de suero. Simultáneamente se observaron las condiciones generales de los ovinos durante el esquema de hiperinmunización, no presentándose alteraciones generales ni locales como consecuencia de la inoculación del veneno. En los resultados se observaron variaciones individuales en la magnitud de la elevación del título de anticuerpos y rasgos comunes en el comportamiento de las curvas desarrolladas. El título promedio óptimo (705,5 µg/ml), fue obtenido el día 21 posterior a la primera inoculación. Para ese momento, el ovino con título más alto fue de 840µg/ml y el más bajo, de 593 µg/ml. El promedio más bajo (308 µg/ml) fue observado el día 56. Se recomienda que los animales que serán utilizados en la producción comercial de antiveneno sean evaluados individualmente y seleccionados con base a una respuesta inmune satisfactoria.

A group of four (4) healthy male sheep were immunized with Bothrops asper venom, in order to study the development of the immune response induced by the application of a hiperimmunization protocol. Blood samples were taken from the sheep every seven days in nine different opportunities. With the resultant serum, neutralization tests were done in mice. ED50 was calculated and expressed in µg of neutralized venom per ml of serum, at the same time, general health conditions of sheep were observed during the hiperimmunization protocol. No general or local alterations of health were present as consequence of venom inoculations. Individual variations in the magnitude of the increase of antibody titles were observed in the obtained results. None the less common features in the antibody title curves were also recorded. The mean optimal average (705,5 µg/ml) was obtained on day 21 after the first challenge. At that time, the individual sheep with the highest value was 840 µg/ml and the lowest was 593 µg/ml; the lowest average of all samples (308 µg/ml ) was observed on day 56. It is recommend that animals to be used in the commercial venom antiserum production need to be individually screened and selected based on a satisfactory immune response.

Edema induced by Bothrops asper (Squamata: Viperidae) snake venom and its inhibition by Costa Rican plant extracts

We tested the capacity of leaf (Urera baccifera, Loasa speciosa, Urtica leptuphylla, Chaptalia nutans, and Satureja viminea) and root (Uncaria tomentosa) extracts to inhibit edema induced by Bothrops asper snake venom. Edema-forming activity was studied plethysmographically in the rat hind paw model. Groups of rats were injected intraperitoneally with various doses of each extract and, one hour later, venom was injected subcutaneously in the right hind paw. Edema was assessed at various time intervals. The edematogenic activity was inhibited in those animals that received an injection U. tomentosa, C. nutans or L. speciosa extract. The extract of U. baccifera showed a slight inhibition of the venom effect. Extract from S. viminea and, to a lesser extent that of U. leptuphylla, induced a pro-inflammatory effect, increasing the edema at doses of 250 mg/kg at one and two hours.

Se investigó la capacidad de los extractos de las hojas de Urera baccifera, Loasa speciosa, Urtica leptuphylla, Chaptalia nutans, Satureja viminea y de la raíz de Uncaria tomentosa para inhibir el edema inducido por el veneno de Bothrops asper por métodos pletismométricos. Los grupos de ratas fueron inyectados intraperitonealmente con varias dosis de cada extracto y una hora mas tarde se inyectó veneno por vía subcutánea en la pata trasera derecha de la rata. Se evaluó el edema en distintos intervalos de tiempo. Los resultados muestran que la actividad edematogénica fue inhibida en los animales que recibieron los extractos de raíz de U. tomentosa, hojas de C. nutans y L. speciosa. Los extractos de hojas de U. baccifera mostraron leve inhibición del efecto del veneno. El extracto de hojas de S. viminea y en menor grado el de U. leptuphylla indujeron un efecto pro inflamatorio.

Características bioquímicas y capacidad neutralizante de cuatro antivenenos polivalentes frente a los efectos farmacológicos y enzimáticos del veneno de Bothrops Asper y Porthidium Nasutum de Antioquia y Chocó / Biochemical characteristics and neutralizing capacity of four polyvalent antivenoms against the pharmacological and enzymatic effects of the venom of Bothrops Asper and Porthidium Nasutum from Antioquia and Chocó

En Colombia, el 90-95 por ciento de las 3000 mordeduras de serpientes informadas cada año, son ocasionadas por Bothrops sp, con una elevada mortalidad y secuelas. Siguiendo recomendaciones de la OMS, se evaluó la capacidad neutralizante de los efectos farmacológicos y enzimáticos de los venenos de Bothrops asper y Porthidium nasutum de Antioquia y Chocó por cuatro antivenenos; 2 de ellos de IgG completa (polivalente antibothrópico, anticrotálico del Instituto Nacional de Salud INS -Colombia; polivalente antibothrópico, anticrotálico, antilachésico de Laboratorios Probiol -Colombia) y 2 antivenenos de fragmentos F(ab')2 (polivalente antibothrópico, anticrotálico del Centro de Biotecnología de la Universidad Central de Venezuela; y el polivalente antibothrópico, anticrotálico Antivipmyn® del Instituto Bioclón -México). Se determinó la actividad letal, hemorrágica, desfibrinante, edematizante, mionecrosante y hemolítica indirecta de cada veneno, siguiendo métodos ya estandarizados. Las pruebas de neutralización in vitro e in vivo se realizaron por el método de preincubación a 370C de dosis fijas de veneno y dosis variables de antiveneno. Los antivenenos Antivipmyn® de México y polivalente INS de Colombia tuvieron la mayor potencia neutralizante de todos los efectos farmacológicos y enzimáticos del veneno de B. asper y P. nasutum. El antiveneno polivalente Probiol fue el de menor capacidad neutralizante y mayor concentración de proteínas. Los antivenenos de fragmentos F(ab')2 tuvieron más baja concentración de proteínas y solo cantidades menores de proteínas no inmunes por electroforesis.